Boston Trust Walden Corp Johnson & Johnson Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Boston Trust Walden Corp holds 1,093,709 shares of JNJ stock, worth $169 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares

1,093,709

Previous 1,024,681 6.74%

Holding current value

$169 Million

Previous $150 Million 18.35%

% of portfolio

1.25%

Previous 1.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$145.48 - $167.38 $10 Million - $11.6 Million	69,028 Added 6.74%	1,093,709 $177 Million
Q2 2024 Jul 19, 2024	SELL	$144.38 - $157.78 $5.54 Million - $6.05 Million	-38,349 Reduced 3.61%	1,024,681 $150 Million
Q1 2024 Apr 22, 2024	BUY	$155.22 - $162.74 $2.22 Million - $2.33 Million	14,331 Added 1.37%	1,063,030 $168 Million
Q4 2023 Jan 24, 2024	BUY	$145.6 - $158.88 $2.8 Million - $3.06 Million	19,237 Added 1.87%	1,048,699 $164 Million
Q3 2023 Oct 18, 2023	BUY	$155.75 - $174.48 $2.16 Million - $2.42 Million	13,898 Added 1.37%	1,029,462 $160 Million
Q2 2023 Jul 24, 2023	BUY	$154.35 - $166.11 $3.07 Million - $3.31 Million	19,919 Added 2.0%	1,015,564 $168 Million
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $2 Million - $2.39 Million	13,258 Added 1.35%	995,645 $154 Million
Q4 2022 Jan 20, 2023	BUY	$160.2 - $179.79 $12 Million - $13.5 Million	74,831 Added 8.25%	982,387 $0
Q3 2022 Oct 19, 2022	BUY	$161.33 - $179.52 $12.6 Million - $14 Million	78,136 Added 9.42%	907,556 $148 Million
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $10.5 Million - $11.6 Million	62,503 Added 8.15%	829,420 $147 Million
Q1 2022 Apr 20, 2022	BUY	$158.14 - $179.59 $7.25 Million - $8.24 Million	45,865 Added 6.36%	766,917 $136 Million
Q4 2021 Jan 21, 2022	BUY	$155.93 - $173.01 $10.7 Million - $11.8 Million	68,381 Added 10.48%	721,052 $123 Million
Q3 2021 Oct 25, 2021	BUY	$161.5 - $179.47 $4.62 Million - $5.13 Million	28,609 Added 4.58%	652,671 $105 Million
Q2 2021 Jul 22, 2021	SELL	$159.48 - $171.07 $1.65 Million - $1.77 Million	-10,322 Reduced 1.63%	624,062 $103 Million
Q1 2021 Apr 21, 2021	BUY	$153.07 - $170.48 $76,688 - $85,410	501 Added 0.08%	634,384 $104 Million
Q4 2020 Jan 15, 2021	BUY	$137.11 - $157.38 $303,150 - $347,967	2,211 Added 0.35%	633,883 $99.8 Million
Q3 2020 Oct 14, 2020	SELL	$140.38 - $153.83 $191,759 - $210,131	-1,366 Reduced 0.22%	631,672 $94 Million
Q2 2020 Jul 23, 2020	SELL	$128.81 - $155.51 $834,817 - $1.01 Million	-6,481 Reduced 1.01%	633,038 $89 Million
Q1 2020 Apr 21, 2020	SELL	$111.14 - $153.99 $3.86 Million - $5.35 Million	-34,758 Reduced 5.15%	639,519 $83.9 Million
Q4 2019 Jan 10, 2020	SELL	$127.5 - $146.44 $9.45 Million - $10.9 Million	-74,132 Reduced 9.91%	674,277 $98.4 Million
Q3 2019 Oct 21, 2019	SELL	$126.95 - $142.14 $2.72 Million - $3.04 Million	-21,389 Reduced 2.78%	748,409 $96.8 Million
Q2 2019 Jul 25, 2019	SELL	$131.15 - $144.24 $181,380 - $199,483	-1,383 Reduced 0.18%	769,798 $107 Million
Q1 2019 Apr 16, 2019	SELL	$125.72 - $139.79 $5.02 Million - $5.58 Million	-39,906 Reduced 4.92%	771,181 $108 Million
Q4 2018 Jan 17, 2019	SELL	$122.84 - $147.84 $641,470 - $772,020	-5,222 Reduced 0.64%	811,087 $105 Million
Q3 2018 Oct 23, 2018	BUY	$121.58 - $142.88 $355,499 - $417,781	2,924 Added 0.36%	816,309 $113 Million
Q2 2018 Jul 25, 2018	BUY	$119.4 - $131.76 $332,648 - $367,083	2,786 Added 0.34%	813,385 $98.7 Million
Q1 2018 Apr 13, 2018	BUY	$125.1 - $148.14 $31,900 - $37,775	255 Added 0.03%	810,599 $104 Million
Q4 2017 Jan 29, 2018	BUY	$131.22 - $143.62 $757,401 - $828,974	5,772 Added 0.72%	810,344 $113 Million
Q3 2017 Oct 13, 2017	BUY	$129.47 - $135.38 $104 Million - $109 Million	804,572	804,572 $105 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Johnson & Johnson Transaction History